Bicara Therapeutics (NASDAQ:BCAX) Stock Rating Lowered by Wall Street Zen
Bicara Therapeutics (NASDAQ:BCAX – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Thursday. Other analysts have also issued reports about the stock. Wedbush reaffirmed an “outperform” rating and set a $31.00 price objective on […]
Bicara Therapeutics (NASDAQ:BCAX – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Thursday. Other analysts have also issued reports about the stock. Wedbush reaffirmed an “outperform” rating and set a $31.00 price objective on […]
